Description

(13As)-5,8,13,13Aα-Tetrahydro-2,9,10-Trimethoxy-6H-Dibenzo[A,G]Quinolizin-1-Ol is a complex, high-purity alkaloid derivative of significant interest in advanced organic synthesis and pharmaceutical research. Its intricate tetracyclic dibenzoquinolizine structure makes it a valuable key intermediate for developing novel bioactive compounds. This product is primarily utilized by research institutions, pharmaceutical R&D laboratories, and fine chemical manufacturers engaged in the synthesis of specialized molecules for pharmacological studies.

Application

• Pharmaceutical Intermediate: Serves as a critical building block in the synthesis of potential drug candidates targeting neurological and other therapeutic areas.
• Organic Synthesis Research: Used as a sophisticated starting material or intermediate in academic and industrial research for constructing complex heterocyclic frameworks.
• Reference Standard: Employed as a high-purity analytical standard in method development and quality control for related compound analysis.
• Biochemical Research: Investigated for its biological activity and interactions in pharmacological and biochemical assay systems.
• Fine Chemical Production: Integrated into multi-step synthesis processes for producing specialized, high-value chemical entities.

Basic Information

Product Name	(13As)-5,8,13,13Aα-Tetrahydro-2,9,10-Trimethoxy-6H-Dibenzo[A,G]Quinolizin-1-Ol
CAS No.	40141-47-7
Molecular Formula	C21H23NO4
Molecular Weight	353.41 g/mol
Synonyms	1-Hydroxy-2,9,10-trimethoxy-5,8,13,13a-tetrahydro-6H-dibenzo[a,g]quinolizine; (13aS)-1-Hydroxy-2,9,10-trimethoxy-5,8,13,13a-tetrahydro-6H-dibenzo[a,g]quinolizine; 2,9,10-Trimethoxy-13a,5,8,13-tetrahydro-6H-dibenzo[a,g]quinolizin-1-ol; Dibenzoquinolizine alkaloid derivative
EINECS	Contact for details

Quality Control

Our (13As)-5,8,13,13Aα-Tetrahydro-2,9,10-Trimethoxy-6H-Dibenzo[A,G]Quinolizin-1-Ol is produced under strict quality management protocols to ensure batch-to-batch consistency and high purity, suitable for demanding research applications. Each lot is accompanied by a comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles. We adhere to cGMP principles where applicable to support its use in pharmaceutical development.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (typically 15-25°C). The compound may be light-sensitive; therefore, containers should be opaque or stored in dark conditions. For long-term storage, consider inert atmosphere conditions to maintain optimal stability.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 97.0%
Related Substances (HPLC)	Total impurities ≤ 3.0%
Residual Solvents (GC)	Complies with ICH guidelines
Water Content (KF)	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.